PROVIDER LED CARE | IV AND TARGETED OPTIONS | CONSULTATION REQUIRED | HOOD RIVER, OREGON
WHAT IT ACTUALLY IS
Working with the communication your body already uses.
Stem cells and exosomes are best understood as carriers. They deliver natural growth factors and cytokines, the same signaling molecules your body already produces and relies on, to help cells communicate.
At Outbound, the products we use are derived from donated umbilical cord tissue, collected only after healthy births with full donor consent and health screening. They are processed at a facility registered with the FDA and handled under strict manufacturing standards.
What we offer is a way to support the signaling pathways your body already uses, guided by a provider who will walk you through exactly what that means for you. Start with a free consult.
INVEST IN YOUR HEALTH
starting at $5,000
“This is not a shortcut and it is not a cure. It is a way to work with your biology thoughtfully and with real oversight.”
What these signals are involved in
THE BIOLOGY
Growth factors and cytokines participate in natural processes your body relies on every day.
WHO IS IT FOR
There is no checklist that answers this. The only way to know is a real conversation about your history, your goals, and what the research does and does not currently show for your particular situation. We would rather have that honest conversation with you than make a promise we cannot keep.
We also encourage you to loop in your primary care provider before moving forward, especially if you are managing a chronic condition or taking regular medications.
START WITH A FREE CONSULTATION
Curious whether this fits your goals? That is exactly what the consultation is for. We will connect you directly with the expert to walk through your questions and options. No pressure.
IV or injection, depending on your goals
IV infusion delivers product through the bloodstream, for a broader, whole body approach. Sessions typically run thirty to sixty minutes, followed by a short observation period.
Targeted injection places product directly at a specific site, such as a joint or tendon area. These sessions are typically brief.
Which path makes sense depends on your history and your goals, and that is exactly what your consultation is for.
What to expect
Most patients describe the visit as similar to any other IV or injection appointment. Mild, temporary discomfort is common. Many people return to light activity within a day or two, and your provider will walk you through any timing considerations before and after your visit.
Some patients notice changes within the first few weeks. For others, meaningful changes take a couple of months. Everyone's biology responds differently, and no specific outcome or timeline can be promised.
Understanding the program before deciding
COMMON QUESTIONS
-
No. The stem cell and exosome products offered through this program are not FDA approved to treat, cure, or prevent any disease or condition. A manufacturer’s FDA registration is not the same as FDA approval of a product. Research is ongoing, and no particular result can be promised.
-
The products used at Outbound are derived from donated umbilical cord tissue collected after healthy births. Donation occurs with informed consent and donor health screening. The material is processed by a manufacturer registered with the FDA.
During your consultation, we can explain the product’s source, how it is processed, and what supporting documentation is available. -
This answer must be confirmed for the exact product Outbound uses. Birth-tissue products vary: some are cell-free and contain signaling components, while others may contain viable cells.
Before treatment, we will explain exactly what the product contains based on its current labeling and manufacturer documentation.
-
Possible risks include temporary discomfort, bruising, bleeding, swelling, infection, inflammatory or immune reactions, and unexpected adverse events. IV administration also carries risks associated with placing an IV and receiving an infusion. Targeted injections may carry additional risks involving nearby tissue, nerves, or blood vessels.
Because these products are not FDA approved for treating medical conditions, their complete safety profile and effectiveness have not been established. Lydia will discuss the risks that apply to your health history and the proposed method of administration before you decide whether to proceed. -
That decision depends on your medical history, your goals, the area you want to address, and the potential risks of each approach.
An IV infusion distributes the product through the bloodstream for a broader approach. A targeted injection places the product at a specific joint, tendon, or other treatment area. Neither method guarantees a particular outcome. We will help you understand the differences and tell you plainly if neither option is an appropriate fit. -
This therapy is not appropriate for everyone. Treatment may need to be postponed or avoided for people with an active infection, pregnancy or breastfeeding, certain immune or clotting disorders, active cancer, significant allergies, or an unstable medical condition. Some medications may also affect whether treatment is appropriate.
A licensed provider must review your complete health history, medications, allergies, and current care before treatment. Do not stop or change a prescribed medication without speaking with the clinician who prescribed it.
Stem cell and exosome products are not FDA approved to treat, cure, or prevent any disease or condition. This page is for education only and is not medical advice. A consultation with a licensed provider is required before any treatment, and we encourage every patient to speak with their primary care provider as part of that decision.